FABRAZYME® (Agalsidase beta) is used in the treatment of Fabry Disease by replacing a missing enzyme that lowers the amount of GL-3 being deposited in the lining of blood vessels.

FABRAZYME® is manufactured by Sanofi Genzyme.

Quick Rx can provide medications and help schedule infusions through its affiliated company, Specialty Infusion Centers. In addition, our highly specialized pharmacists work closely with nurse practitioners to offer initial and ongoing clinical monitoring. For further questions, please call 212-2infuse (212-246-3873)

Partnered with: